Efeitos da atorvastatina sobre a infecção experimental por Leishmania major no camundongo C57BL/6

AUTOR(ES)

Fernanda Oliveira Ferraz

DATA DE PUBLICAÇÃO

2008

RESUMO

Statins are inhibitors of b-hidroxi-b-metil-Co A reductase (the rate limiting enzyme of cholesterol synthesis), so they are the first choice drugs for hipercholesterolemy therapy. Nowadays, statins are some of the most prescribed drugs in the world and their use as prophylactic agents for cardiovascular diseases has been widely suggested. Atorvastatin, an extremely diffused statin, can also modulate immune response when applied clinically or in experimental models and presents immunosuppressor and anti-inflammatory actions. Knowing its potential of suppressing Th1 immune response, this work was focused in the study of the effect of atorvastatin in experimental infection with Leishmania major in C57BL/6 mice, the resistance model against this parasite. In this model, parasite growth is controlled by a Th1 response developed by the host. Our results showed that atorvastatin treatment favored parasite proliferation. When the time of statin administration was controlled, a significant increase in footpad lesion was observed, indicating that the effect of atorvastatin in mice is modulated by the circadian cycle. Atorvastatin did not inhibited the type 1 immune response polarization, since in treated animals increased IFN-g , TNF-a and CCL5/RANTES production and NOS II activity were observed. On the other hand, statin activated regulatory mechanisms of the immune response such as CD4+CD25high cells with an increment in TGF-b and IL-10 production and arginase I activity as consequences. According to our findings, long term treatment with atorvastatin compromises the control of L. major infection in C57BL/6 mice. Our results also suggest that atorvastatin widespread use must be carefully evaluated, especially in populations that live in endemic areas for parasitic diseases such as leishmaniasis.

ASSUNTO(S)

leishmania major camundongo c57bl/6 atorvastatina imunologia

Documentos Relacionados

• Ineficácia in vivo da terbinafina em leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL/6
• Biochemical association between essential trace elements and susceptibility to Leishmania major in BALB/c and C57BL/6 mice
• Low and high-dose intradermal infection with Leishmania majorand Leishmania amazonensis in C57BL/6 mice
• EXPERIMENTAL SUBCUTANEOUS CYSTICERCOSIS BY Taenia crassiceps IN BALB/c AND C57BL/6 MICE
• Avaliação de resposta imunológica aguda de camundongos c57bl/6 e balb/c frente à infecção por mycobacterium massiliense